Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03764514 · ClinicalTrials.gov registry record

Spinal Cord Stimulation in Chemotherapy Induced Neuropathy

A clinical trial of Chemotherapy-induced Peripheral Neuropathy, sponsored by Prisma Health-Upstate.

Completed
Registry status
5
Enrollment target
1
Study location

NCT03764514: Completed study of Chemotherapy-induced Peripheral Neuropathy, sponsored by Prisma Health-Upstate.

NCT03764514 is a study of Chemotherapy-induced Peripheral Neuropathy that has completed, run by Prisma Health-Upstate. The registered enrollment target is 5 participants, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03764514, a study of Chemotherapy-induced Peripheral Neuropathy, has completed, sponsored by Prisma Health-Upstate.

COMPLETED
Registry status
5 participants
Enrollment target
1
Study location

Study Summary

This is an observational based pilot study evaluating the use of spinal cord stimulators for the treatment of chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and decrease in pain.

Primary Outcome

To determine the total number of patients who undergo permanent spinal cord stimulator implantation.

Conditions Studied

Chemotherapy-induced Peripheral Neuropathy

Interventions

  • DEVICE Spinal Cord Stimulator

Study Locations (1)

South Carolina

  • Patewood Memorial Hospital - Greenville

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-12-03
Est. Completion 2022-05-03
Prisma Health-Upstate

67 total trials

What the finished NCT03764514 record still lists

NCT03764514 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Chemotherapy-induced Peripheral Neuropathy appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulator is the first listed.

NCT03764514 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT03764514 about?

NCT03764514 is a clinical study titled "Spinal Cord Stimulation in Chemotherapy Induced Neuropathy". This is an observational based pilot study evaluating the use of spinal cord stimulators for the treatment of chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and decrease in pain.

What is the current status of trial NCT03764514?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2018-12-03. Estimated completion is 2022-05-03.

What conditions does trial NCT03764514 study?

This clinical trial studies the following conditions: Chemotherapy-induced Peripheral Neuropathy.

What interventions are being tested in trial NCT03764514?

The interventions under investigation include: Spinal Cord Stimulator (DEVICE).

Who is sponsoring clinical trial NCT03764514?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03764514 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chemotherapy-induced Peripheral Neuropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03764514's enrollment target sits among peer trials

5 30th of 29 the lowest of 29 other Chemotherapy-induced Peripheral Neuropathy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chemotherapy-induced Peripheral Neuropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03764514, the US trial registry maintained by the National Library of Medicine. NCT03764514 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.